Summary of Product Characteristics
last updated on the eMC:
10/03/2008
|
SPC
|
Anusol HC Suppositories
|
Go to top of the pageGo to top of the page | Each suppository contains:Hydrocortisone acetate 10mgBismuth subgallate 59mgBismuth oxide 24mgBalsam Peru 49mgBenzyl benzoate 33mgZinc oxide 296mg | |
Go to top of the page | White/off white suppository. | |
Go to top of the pageGo to top of the page | Anusol HC Suppositories are indicated for the symptomatic relief of internal haemorrhoids and pruritus ani. | |
Go to top of the page | Anal insertion. ADULTS Remove wrapper and insert one suppository into the anus at night, in the morning and after each evacuation.Not to be taken orally.ELDERLY (OVER 65 YEARS) As for adults.CHILDREN Not recommended. | |
Go to top of the page | Tubercular, fungal and most viral lesions including herpes simplex, vaccinia and varicella. History of sensitivity to any of the constituents. | |
Go to top of the page | Following symptomatic relief, definitive diagnosis should be established. | |
Go to top of the pageGo to top of the page | There is inadequate evidence of safety in human pregnancy and there may be a very small risk of cleft palate and intrauterine growth retardation as well as suppression of the neonatal HPA axis. There is evidence of harmful effects in animals. Use in pregnancy only when there is no safer alternative and when the disease itself carries risks for the mother or child. | |
Go to top of the pageGo to top of the page | As with all products containing topical steroids the possibility of systemic absorption should be borne in mind. Prolonged or excessive use may produce systemic corticosteroid effects, and use for periods longer than seven days is not recommended. Rarely, there are sensitivity reactions. Patients may occasionally experience transient burning on application, especially if the anoderm is not intact. | |
Go to top of the page | If swallowed, fever, nausea, vomiting, stomach cramps and diarrhoea may develop 3-12 hours after ingestion.Hydrocortisone normally does not produce toxic effects in an acute single overdose. Treatment of a large acute overdose should include gastric lavage, purgation with magnesium sulphate and complete bed rest. If necessary, give oxygen and general supportive measures. Methaemoglobinaemia should be treated by intravenous methylthioninium chloride. | |
Go to top of the pageGo to top of the page | This product provides antiseptic, astringent, emollient and anti-inflammatory actions.Bismuth oxide, zinc oxide, and bismuth subgallate exert a protective action on mucous membranes and raw surfaces. They are mildly astringent and are reported to have antiseptic properties.Balsam Peru has protective properties and a very mild antiseptic action by virtue of its content of cinnamic and benzoic acids. It is believed to promote the growth of epithelial cells.Benzyl benzoate is used as a solubilizing agent and has mild antiseptic and preservative properties.Hydrocortisone acetate has the general properties of hydrocortisone and the anti-inflammatory action is of primary interest in this product. | |
Go to top of the page | It is well known that topically applied corticosteroids can be absorbed percutaneously. This appears to be more likely upon repeated or prolonged use.The other active ingredients in Anusol HC Suppositories exert their therapeutic effect without being absorbed into the systemic circulation. These observations are supported by evidence from various studies and reviews. | |
Go to top of the page | Pre-clinical safety data do not add anything of further significance to the prescriber. | |
Go to top of the pageGo to top of the page | Each suppository contains:Kaolin light Suppocire BS2 pastilles (Hard fat) | |
Go to top of the pageGo to top of the pageGo to top of the pageGo to top of the page | Printed strip pack consisting of white opaque PVC/polyethylene laminated film. Boxes of 12 and 24 suppositories. | |
Go to top of the pageGo to top of the pageGo to top of the page | McNeil Products LimitedFoundation ParkRoxborough WayMaidenheadBerkshireS6 3UGUnited Kingdom | |
Go to top of the pageGo to top of the page | 14th August 1998 / 14th January 20021st June 2002 (Transfer of Ownership) | |
Go to top of the page
More information about this product
Link to this document from your website: http://www.medicines.org.uk/emc/medicine/10495/SPC/